11.68
-0.27(-2.26%)
Currency In USD
| Previous Close | 11.95 |
| Open | 12 |
| Day High | 12.03 |
| Day Low | 11.5 |
| 52-Week High | 21.23 |
| 52-Week Low | 9.2 |
| Volume | 846,335 |
| Average Volume | 472,909 |
| Market Cap | 683.4M |
| PE | 7.21 |
| EPS | 1.62 |
| Moving Average 50 Days | 13.81 |
| Moving Average 200 Days | 12.57 |
| Change | -0.27 |
If you invested $1000 in Embecta Corp. (EMBC) since IPO date, it would be worth $268.51 as of December 04, 2025 at a share price of $11.68. Whereas If you bought $1000 worth of Embecta Corp. (EMBC) shares 2 years ago, it would be worth $649.61 as of December 04, 2025 at a share price of $11.68.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
embecta announces changes to Board of Directors
GlobeNewswire Inc.
Nov 17, 2025 10:00 PM GMT
PARSIPPANY, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that David J.
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day
GlobeNewswire Inc.
Nov 14, 2025 11:30 AM GMT
Expanded Partnership Will Increase Access to Diabetes Care for Communities Across the U.S. and GloballyPARSIPPANY, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- On World Diabetes Day, embecta Corp. (“embecta”) (Nasdaq: EMBC), the largest manufacturer of
embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire Inc.
Nov 11, 2025 10:00 PM GMT
PARSIPPANY, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call t